Heidelberg Pharma AG Current Ratio Growth & History (HPHA)

Heidelberg Pharma AG's current ratio was 2.53 for fiscal 2025.

View full Heidelberg Pharma AG company overview

Heidelberg Pharma AG annual current ratio history

Heidelberg Pharma AG annual current ratio

Fiscal yearPeriod endedCurrent ratioChangeGrowth
20252025-11-302.53−3.42−57.50%
20242024-11-305.953.08+107.69%
20232023-11-302.86−0.28−9.01%
20222022-11-303.152.54+421.38%
20212021-11-300.60−0.53−46.79%
20202020-11-301.13−0.66−36.78%
20192019-11-301.79−2.03−53.05%
20182018-11-303.82−3.18−45.40%
20172017-11-307.006.09+668.49%
20162016-11-300.910.12+15.25%
20152015-11-300.79−0.13−14.48%
20142014-11-300.92−0.38−29.28%
20132013-11-301.31−0.20−13.19%
20122012-11-301.501.11+280.14%
20112011-11-300.40−0.13−24.32%
20102010-11-300.52

Heidelberg Pharma AG current ratio trends

Over the last five fiscal years, Heidelberg Pharma AG's current ratio increased from 1.13 to 2.53, a change of 1.39. The latest reported quarter, Q2 2026, shows 5.29.

About the metric

What the current ratio means

The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.

Calculation and source

How the current ratio is calculated

TickerStat calculates the current ratio as reported current assets divided by reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Heidelberg Pharma AG source filings ↗

Community posts

It’s quiet here.

No posts about HPHA yet. Start the conversation.

Write the first post